The average died per minute was 2.5 people, and the hazards of slow lung disease were ignored.

There are about 100 million patients with slow pulmonary disease in my country, which is the third roughly mortal disease. However, in our country, it is not commensurate with the high incidence, high mortality, and high socio -economic burden on slow -obstructing pulmonary disease. my country ’s prolifiers in China are facing low -awareness, low diagnosis, and low standardized treatment rates. challenge. Today, the "Breathing and the Communist Party's Health-2022 National Chronic Breathing Disease Health Action Plan" and the "Shu Chang Biking Action" were officially launched. The operation was initiated by the China Junior Health Care Foundation. The Chinese Medical Association Breathing Physician Branch, the Chinese Medical Association's Respiratory Diseases Branch, and the Child Pulmonary Student Group were promoted to enhance the public cognition of slow pulmonary disease. The harm of acute aggravation advocates the standardized diagnosis and treatment of slow pulmonary disease.

"Lung Healthy Killer", 97.4%of patients do not know slowly blocking pulmonary disease

Chronic obstructive pulmonary disease, also known as chronic obstructive pulmonary disease, is a lung disease that can prevent and treat it with continuous airflow. Cough, sputum, and asthma are the main symptoms. Among them, it is characterized by difficulty in breathing after activity. As a key prevention and treatment of diseases in the Healthy China 2030 Action Plan, the prevalence and disease mortality of chronic obstructive pulmonary disease in China remains high, and the prevention and control situation is extremely severe. At present, the number of people who die due to slow lung disease every year in my country exceeds 1 million, accounting for one -third of the world, with an average of 2.5 deaths per minute. The mortality and disease burden are much higher than the world average.

Chronic respiratory diseases represented by slow pulmonary disease have seriously affected the health level of the public, but the status quo of prima prevention and control and diagnosis and treatment in my country is not optimistic. Three%of patients with slow pulmonary disease know that they are sick, and only about 10%of patients are diagnosed correctly. At present, the current status of the diagnosis and treatment of slow pulmonary disease in my country mainly has an underestimation of the disease itself. The diagnosis rate of diagnosis and treatment is low, irregular treatment, low cognitive disease cognition, and poor compliance. The public lack of cognitive delay diagnosis and treatment and insufficient attention is enough to be the basic cause of insufficient diagnosis and treatment. Patients with up to 97.4%of patients do not know slow obstructive pulmonary disease. Patients with 4/5 slow lung disease have not followed standardized treatment.

Vice Dean of the Chinese Academy of Engineering, the dean of the Chinese Academy of Medical Sciences, the president of the Peking Union Medical College, and the director of the State Breathe Medicine Center, pointed out in his speech that the disease rate of chronic pulmonary disease in people over the age of 40 is 13.7%. However, the society and the public And the medical community's attention to slow pulmonary disease is far from enough, and the serious insufficient cognition of the severity, symptoms and norms of slow pulmonary disease, which is increasingly increasing the public awareness and attention. At the same time, he specifically proposed the "six -in -one" respiratory health care concept of health promotion, disease prevention, diagnosis, control, treatment, and rehabilitation, and emphasized that "prevention and control of the diagnosis and control" is a key link in the prevention and control of slow pulmonary disease.

Slow -blocked lung disease "comfortable breathing action" came into being. Zhou Qingnian, vice chairman of the China Junior Health Care Foundation, said that the action aims to cooperate with multiple parties to promote the improvement of the prevention and control of prima in my country and help more patients to benefit.

Acute aggravation and complications are highly harmful, and the key to standardizing diagnosis and treatment

For patients with slow pulmonary disease, acute aggravation is the key factor in accelerating the progress of the disease and eventually leading to death. 81.6%of patients with acute aggravation of high -risk of prostitution in my country accounted for 81.6%, and 22%of patients with slow pulmonary patients died within one year after the first severe acute aggravation, and only 50%of patients survived within 3.6 years after the first severe acute aggravation.

The acute aggravation of slow pulmonary disease can be killed by directly promoting the advancement of slow pulmonary disease to respiratory failure and indirectly promoting the risk of complications. Common complications include stroke, lung cancer, cardiovascular disease, etc. However, compared to other deaths, in addition to the prone to the death of the deprivation of slow obstruction of the pulmonary disease, the acute aggravation of the acute increase in slow pulmonary disease is the promoter behind the three roughly death diseases.

Professor Yang Ting, deputy director of the Department of Respiratory and Critical Medicine of China -Japan Hospital, pointed out that the disease of slow obstruction of pulmonary disease was hidden, and "missed diagnosis and misdiagnosis" occurred. Therefore, people over 40 years of age should pay attention to lung function screening and do a good job "Early diagnosis and early treatment." It should also be emphasized that it is necessary to pay attention to the diagnosis and treatment of proclabbral disease in slow pulmonary disease and related complications, especially the identification and standardized treatment of acute aggravation.

A study from Sweden's correlation between slow pulmonary block and stroke shows that during the decade of follow -up, among patients who were surveyed at the age of 40 to 84 and had previously no stroke, the probability of the stroke incident was about It accounts for 16.82%. The study also found that the damage to lung function caused by the acute aggravation of the pulmonary blockage can increase the risk of stroke. In addition, it has confirmed that proclabbral disease is one of the important risk factors for the high mortality rate of lung cancer. The probability of common diseases for mixed prochabital pulmonary patients with lung cancer can reach 39.8%.

The damage of the acute aggravation of the prolifiers of the pulmonary block is not only not only lung and brain, but also increases the risk of cardiovascular disease. Patients with cardiovascular diseases are combined with cardiovascular disease. The risk of cardiovascular events after acute aggravation increases. According to research data, the risk of cardiovascular disease in patients with proclastic disease diseases is twice as much as non -proclabbing patients.

Based on the risk of death caused by the acute aggravation of the pulmonary, it is necessary to promote standardized diagnosis and treatment and full -disease management. Professor Qu Jieming, Secretary of the Party Committee of Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, said that with the efforts of many parties, chronic pulmonary disease has been included in the "Healthy China 2030 Action" key prevention and treatment of diseases. Take care of the patient from the "six -in -one" angle. Improve the level of the grassroots level and promote the incorporation of slow lung disease into the national public health system

my country has a vast across, improving diagnosis and treatment capabilities, especially primary medical workers, and the emphasis on primary diseases, as well as the treatment capabilities and standardized treatment capabilities. There are 100 million patients with prolifiers in China. Patients need long -term medication, follow -up management, and rehabilitation treatment. The examination and treatment costs incurred have caused great economic burden and medical and health resources to patients, society and the country. Expert analysis said that if slow pulmonary disease is included in basic public health service projects, grass -roots medical institutions are responsible for the first consultation and long -term management. It can not only promote the standardized management of patients with slow pulmonary disease, but also relieve the pressure brought by the national medical and health resources through the construction of the respiratory disease system of grass -roots health institutions to alleviate the slow objection.

Industry experts have made continuous efforts and achieved results in promoting the addition of primary pulmonary disease to join the national basic public health system. As the chairman of this conference, Professor Chen Rongchang, director of the Institute of Respiratory Diseases of Shenzhen People's Hospital, said that most of the public health service projects are carried out in grassroots medical institutions, which are usually said to be urban community health services centers, rural township health centers , Community health service stations, etc., should be incorporated into basic public health service projects as soon as possible to enhance the awareness rate of public diseases, and promote "early diagnosis and early treatment". Medical institutions are equipped with portable lung function instruments, popularize lung function tests, and use training to improve the ability of grassroots medical personnel to "prevent, manage, and health", and ultimately benefit the majority of patients.

As one of the project supporters, the vice president of Astracon China, Lin Xiao, the head of the breathing, digestion and autoimmune division, said that Astraikon will continue to bring global innovative drugs in the field of breathing to China, and jointly promote China with various parties to promote China Features of the management method of slow respiratory disease diagnosis and treatment to improve the survival rate and quality of survival of patients. It is reported that the "Shuchang Breathing Action" will carry out various activities such as famous medical science science science science, patient stories, and famous doctors interviews such as disease cognition.

---

Author: Tang Wenjia

Edit: Tang Wenjia

Editor in charge: Fan Liping

Figure: Provided by the interviewer

---

*Wenhui exclusive manuscript, please indicate the source for reprinting.

- END -